RIGL - Rigel Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RIGL is currently covered by 5 analysts with an average price target of $53.47. This is a potential upside of $12.69 (31.12%) from yesterday's end of day stock price of $40.78.

Rigel Pharmaceuticals's activity chart (see below) currently has 75 price targets and 88 ratings on display. The stock rating distribution of RIGL is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.87% with an average time for these price targets to be met of 672.27 days.

Highest price target for RIGL is $57, Lowest price target is $20.45, average price target is $37.69.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 06-Aug-2025. First documented stock forecast 13-Jul-2016.

Currently out of the existing stock ratings of RIGL, 4 are a BUY (50%), 4 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$32

$-18.49 (-36.62%)

$23

4 months 9 days ago
(06-Aug-2025)

5/6 (83.33%)

$2.19 (7.35%)

70

Hold

$20.45

$-30.04 (-59.50%)

$10

7 months 8 days ago
(07-May-2025)

5/7 (71.43%)

$1.98 (10.72%)

1440

Buy

$55

$4.51 (8.93%)

$49

9 months 9 days ago
(06-Mar-2025)

3/6 (50%)

$35.3 (179.19%)

422

Hold

$24

$-26.49 (-52.47%)

$20

9 months 10 days ago
(05-Mar-2025)

7/7 (100%)

$3.71 (18.28%)

275

Buy

$57

$6.51 (12.89%)

$57

9 months 10 days ago
(05-Mar-2025)

1/9 (11.11%)

$36.71 (180.93%)

1681

Show more analysts

Please expand the browser size to see the chart

What is RIGL (Rigel Pharmaceuticals) average time for price targets to be met?

On average it took 672.27 days on average for the stock forecasts to be realized with a an average price target met ratio 43.87

Which analyst has the current highest performing score on RIGL (Rigel Pharmaceuticals) with a proven track record?

GARY NACHMAN

Which analyst has the most public recommendations on RIGL (Rigel Pharmaceuticals)?

Gary Nachman works at RAYMOND JAMES and has 14 price targets and 8 ratings on RIGL

Which analyst is the currently most bullish on RIGL (Rigel Pharmaceuticals)?

Joseph Pantginis with highest potential upside - $6.51

Which analyst is the currently most reserved on RIGL (Rigel Pharmaceuticals)?

Anupam Rama with lowest potential downside - -$44.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?